Departments of Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Rheumatology (Oxford). 2020 Mar 1;59(Suppl 1):i37-i46. doi: 10.1093/rheumatology/kez383.
Psoriatic arthritis (PsA) is a complex inflammatory musculoskeletal and skin disease. The treatment of PsA has changed substantially over the past 10 years. Clinical practice guidelines are developed to help busy clinicians rapidly integrate evolving knowledge of therapeutic management into practice. In this review, we compare PsA treatment recommendations or guidelines developed by one national organization [ACR and National Psoriasis Foundation (NPF) in 2018], one regional organization (EULAR in 2015), and one international organization (the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis in 2015). We examine the development of guidelines in PsA more broadly and examine similarities and differences in the three sets of recommendations.
银屑病关节炎（PsA）是一种复杂的炎症性肌肉骨骼和皮肤疾病。过去 10 年来，PsA 的治疗方法发生了重大变化。临床实践指南的制定是为了帮助忙碌的临床医生将治疗管理方面不断发展的知识快速融入实践。在这篇综述中，我们比较了由一个国家组织[2018 年的美国风湿病学会（ACR）和国家银屑病基金会（NPF）]、一个地区组织（2015 年的 EULAR）和一个国际组织（2015 年的银屑病和银屑病关节炎研究与评估小组）制定的 PsA 治疗建议或指南。我们更广泛地研究了 PsA 指南的制定，并检查了这三组建议的相似点和不同点。
